| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Internal Medicine I (P.W., H.L.F., C.D.) and Neuroendocrinology (J.B.), University Hospital Schleswig Holstein, D-23538 Luebeck, Germany
Address all correspondence and requests for reprints to: Peter Wellhoener, M.D., University Hospital Schleswig Holstein, Campus Luebeck, Department of Internal Medicine, D-23538 Luebeck, Germany. E-mail: peter.wellhoener{at}innere1.uni-luebeck.de.
Activation of central nervous mineralocorticoid receptors (MRs) has been shown to inhibit the activity of the hypothalamo-pituitary-adrenocortical (HPA) axis in animals. Here, we examined whether MRs in humans likewise regulate HPA activity in response to a physiological stressor. In a balanced, randomized, double-blind, cross-over trial, 12 healthy men were treated with either two injections of 200 mg canrenoate or placebo 24 and 8 h before an intense physical exercise taking place between 1600 and 1700 h. Exercising was preceded by a 60-min rest period and followed by another 90-min rest. Blood was collected in regular intervals to determine ACTH, cortisol, and human GH (hGH). Exercise induced a significant rise in cortisol, ACTH, and hGH. Cortisol levels, however, were significantly higher after canrenoate, compared with placebo, whereas ACTH and hGH concentrations did not differ. The increase in cortisol was already significant during rest before exercise and continued to be elevated throughout the whole experiment. We conclude that MR blockade leads to a tonically increased cortisol secretion both during rest and under stimulation. The undiminished concentration of ACTH in the presence of elevated cortisol levels suggests that blockade of MR shifts the set point for cortisol feedback inhibition of the HPA axis toward higher cortisol levels.
This article has been cited by other articles:
![]() |
A. Peters, M. Conrad, C. Hubold, U. Schweiger, B. Fischer, and H. L. Fehm The principle of homeostasis in the hypothalamus-pituitary-adrenal system: new insight from positive feedback Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R83 - R98. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Rozeboom, H. Akil, and A. F. Seasholtz Mineralocorticoid receptor overexpression in forebrain decreases anxiety-like behavior and alters the stress response in mice PNAS, March 13, 2007; 104(11): 4688 - 4693. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Goldman, G. Wood, M. B. Goldman, M. Gavin, S. Paul, S. Zaheer, G. Fayyaz, and R. S. Pilla Diminished Glucocorticoid Negative Feedback in Polydipsic Hyponatremic Schizophrenic Patients J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 698 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. DeRijk, S. Wust, O. C. Meijer, M.-C. Zennaro, I. S. Federenko, D. H. Hellhammer, G. Giacchetti, E. Vreugdenhil, F. G. Zitman, and E. R. de Kloet A Common Polymorphism in the Mineralocorticoid Receptor Modulates Stress Responsiveness J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5083 - 5089. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Giordano, M. Bo, M. Pellegrino, M. Vezzari, M. Baldi, A. Picu, M. Balbo, L. Bonelli, G. Migliaretti, E. Ghigo, et al. Hypothalamus-Pituitary-Adrenal Hyperactivity in Human Aging Is Partially Refractory to Stimulation by Mineralocorticoid Receptor Blockade J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5656 - 5662. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |